Literature DB >> 16802299

Recovery from paralysis in adult rats using embryonic stem cells.

Deepa M Deshpande1, Yun-Sook Kim, Tara Martinez, Jessica Carmen, Sonny Dike, Irina Shats, Lee L Rubin, Jennifer Drummond, Chitra Krishnan, Ahmet Hoke, Nicholas Maragakis, Jeremy Shefner, Jeffrey D Rothstein, Douglas A Kerr.   

Abstract

OBJECTIVE: We explored the potential of embryonic stem cell-derived motor neurons to functionally replace those cells destroyed in paralyzed adult rats.
METHODS: We administered a phosphodiesterase type 4 inhibitor and dibutyryl cyclic adenosine monophosphate to overcome myelin-mediated repulsion and provided glial cell-derived neurotrophic factor within the sciatic nerve to attract transplanted embryonic stem cell-derived axons toward skeletal muscle targets.
RESULTS: We found that these strategies significantly increased the success of transplanted axons extending out of the spinal cord into ventral roots. Furthermore, transplant-derived axons reached muscle, formed neuromuscular junctions, were physiologically active, and mediated partial recovery from paralysis.
INTERPRETATION: We conclude that restoration of functional motor units by embryonic stem cells is possible and represents a potential therapeutic strategy for patients with paralysis. To our knowledge, this is the first report of the anatomical and functional replacement of a motor neuron circuit within the adult mammalian host.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16802299     DOI: 10.1002/ana.20901

Source DB:  PubMed          Journal:  Ann Neurol        ISSN: 0364-5134            Impact factor:   10.422


  72 in total

1.  Human stem cells as a model of motoneuron development and diseases.

Authors:  Yan Liu; Su-Chun Zhang
Journal:  Ann N Y Acad Sci       Date:  2010-06       Impact factor: 5.691

2.  Transgenic enrichment of mouse embryonic stem cell-derived progenitor motor neurons.

Authors:  Dylan A McCreedy; Cara R Rieger; David I Gottlieb; Shelly E Sakiyama-Elbert
Journal:  Stem Cell Res       Date:  2011-12-13       Impact factor: 2.020

Review 3.  Human motor neuron generation from embryonic stem cells and induced pluripotent stem cells.

Authors:  M Nizzardo; C Simone; M Falcone; F Locatelli; G Riboldi; G P Comi; S Corti
Journal:  Cell Mol Life Sci       Date:  2010-07-29       Impact factor: 9.261

4.  Preclinical safety validation of a stabilized viral vector direct injection approach to the cervical spinal cord.

Authors:  Thais Federici; Jonathan Riley; John Park; Mark Bain; Nicholas Boulis
Journal:  Clin Transl Sci       Date:  2009-04       Impact factor: 4.689

Review 5.  Intraspinal stem cell transplantation for amyotrophic lateral sclerosis.

Authors:  Kevin S Chen; Stacey A Sakowski; Eva L Feldman
Journal:  Ann Neurol       Date:  2016-02-12       Impact factor: 10.422

Review 6.  The use of brief post-surgical low frequency electrical stimulation to enhance nerve regeneration in clinical practice.

Authors:  K M Chan; M W T Curran; T Gordon
Journal:  J Physiol       Date:  2016-03-24       Impact factor: 5.182

Review 7.  Stem cell-derived motor neurons: applications and challenges in amyotrophic lateral sclerosis.

Authors:  Jason R Thonhoff; Luis Ojeda; Ping Wu
Journal:  Curr Stem Cell Res Ther       Date:  2009-09       Impact factor: 3.828

8.  Discovery, synthesis, and biological evaluation of novel SMN protein modulators.

Authors:  Jingbo Xiao; Juan J Marugan; Wei Zheng; Steve Titus; Noel Southall; Jonathan J Cherry; Matthew Evans; Elliot J Androphy; Christopher P Austin
Journal:  J Med Chem       Date:  2011-08-19       Impact factor: 7.446

9.  Direct muscle delivery of GDNF with human mesenchymal stem cells improves motor neuron survival and function in a rat model of familial ALS.

Authors:  Masatoshi Suzuki; Jacalyn McHugh; Craig Tork; Brandon Shelley; Antonio Hayes; Ilaria Bellantuono; Patrick Aebischer; Clive N Svendsen
Journal:  Mol Ther       Date:  2008-09-16       Impact factor: 11.454

Review 10.  Stem cells in human neurodegenerative disorders--time for clinical translation?

Authors:  Olle Lindvall; Zaal Kokaia
Journal:  J Clin Invest       Date:  2010-01       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.